Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118803216 | 11880321 | 6 | F | 20160803 | 20151230 | 20160808 | EXP | PHHY2015CO098112 | NOVARTIS | 0.00 | F | Y | 65.00000 | KG | 20160808 | CN | COUNTRY NOT SPECIFIED | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118803216 | 11880321 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 1 DF OF 5 MG, BID | U | 22334 | 1 | DF | TABLET | BID | |||||
| 118803216 | 11880321 | 2 | C | EXEMESTANE. | EXEMESTANE | 1 | Oral | 25 MG, QD | U | 0 | 25 | MG | TABLET | QD | |||||
| 118803216 | 11880321 | 3 | C | LYRICA | PREGABALIN | 1 | Unknown | 75 MG, UNK | U | 0 | 75 | MG | |||||||
| 118803216 | 11880321 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 40 MG, UNK | U | 0 | 40 | MG | |||||||
| 118803216 | 11880321 | 5 | C | BISACODYL. | BISACODYL | 1 | Oral | UNK DF, QD | U | 0 | TABLET | QD | |||||||
| 118803216 | 11880321 | 6 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | 20 MG, UNK | U | 0 | 20 | MG | |||||||
| 118803216 | 11880321 | 7 | C | DOLEX FORTE | 2 | Oral | UNK DF, PRN | U | 0 | TABLET | |||||||||
| 118803216 | 11880321 | 8 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | UNK DF, QD | U | 0 | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118803216 | 11880321 | 1 | Breast cancer metastatic |
| 118803216 | 11880321 | 2 | Breast cancer |
| 118803216 | 11880321 | 3 | Product used for unknown indication |
| 118803216 | 11880321 | 4 | Blood cholesterol abnormal |
| 118803216 | 11880321 | 5 | Constipation |
| 118803216 | 11880321 | 6 | Sleep disorder |
| 118803216 | 11880321 | 7 | Pain |
| 118803216 | 11880321 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118803216 | 11880321 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118803216 | 11880321 | Bone pain | |
| 118803216 | 11880321 | Dizziness | |
| 118803216 | 11880321 | Drug dispensing error | |
| 118803216 | 11880321 | Drug interaction | |
| 118803216 | 11880321 | Hypoaesthesia | |
| 118803216 | 11880321 | Malignant neoplasm progression | |
| 118803216 | 11880321 | Myalgia | |
| 118803216 | 11880321 | Nausea | |
| 118803216 | 11880321 | Oral mucosal blistering | |
| 118803216 | 11880321 | Stomatitis | |
| 118803216 | 11880321 | Terminal state | |
| 118803216 | 11880321 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118803216 | 11880321 | 1 | 20150801 | 0 | ||
| 118803216 | 11880321 | 2 | 201508 | 0 |